Cargando…
Calcium Modulation of Toxicities Due to Cisplatin
Cisplatin (CDDP) is a potent anti-neoplastic agent with associated toxicities, especially gastrointestinal and nephrotoxicity that are its dose-limiting factors in clinical oncology. In an attempt to elucidate its mechanism(s) of action, liver and kidney tissues from normal and CDDP treated (1.8 mg/...
Autor principal: | Aggarwal, Surinder K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365104/ https://www.ncbi.nlm.nih.gov/pubmed/18475826 http://dx.doi.org/10.1155/MBD.1998.77 |
Ejemplares similares
-
Role of Vitamin D on the Inhibition of Gastrin Production After Cisplatin Treatment
por: Wang, Ying, et al.
Publicado: (2000) -
Modulation of calcium-binding proteins expression and cisplatin chemosensitivity by calcium chelation in human breast cancer MCF-7 cells
por: Hodeify, Rawad, et al.
Publicado: (2021) -
Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity
por: El-Sheikh, Azza, et al.
Publicado: (2021) -
Ellagic acid modulates cisplatin toxicity in DMH induced colorectal cancer: Studies on membrane alterations
por: Goyal, Yasmeen, et al.
Publicado: (2022) -
Modulation of cisplatin cytotoxicity by sulphasalazine.
por: Awasthi, S., et al.
Publicado: (1994)